IBDEI056 ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6639,0)
 ;;=362.64^^37^405^80
 ;;^UTILITY(U,$J,358.3,6639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6639,1,3,0)
 ;;=3^Reticular Degeneration
 ;;^UTILITY(U,$J,358.3,6639,1,4,0)
 ;;=4^362.64
 ;;^UTILITY(U,$J,358.3,6639,2)
 ;;=Reticular Degeneration^268645
 ;;^UTILITY(U,$J,358.3,6640,0)
 ;;=362.61^^37^405^29
 ;;^UTILITY(U,$J,358.3,6640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6640,1,3,0)
 ;;=3^Degeneration, Paving Stone
 ;;^UTILITY(U,$J,358.3,6640,1,4,0)
 ;;=4^362.61
 ;;^UTILITY(U,$J,358.3,6640,2)
 ;;=Paving Stone Degeneration^268642
 ;;^UTILITY(U,$J,358.3,6641,0)
 ;;=362.42^^37^405^94
 ;;^UTILITY(U,$J,358.3,6641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6641,1,3,0)
 ;;=3^Rpe Detachment, Serous
 ;;^UTILITY(U,$J,358.3,6641,1,4,0)
 ;;=4^362.42
 ;;^UTILITY(U,$J,358.3,6641,2)
 ;;=Serous RPE Detachment^268633
 ;;^UTILITY(U,$J,358.3,6642,0)
 ;;=362.43^^37^405^93
 ;;^UTILITY(U,$J,358.3,6642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6642,1,3,0)
 ;;=3^Rpe Detachment, Hemorrhagic
 ;;^UTILITY(U,$J,358.3,6642,1,4,0)
 ;;=4^362.43
 ;;^UTILITY(U,$J,358.3,6642,2)
 ;;=Hemorrhagic RPE Detachment^268634
 ;;^UTILITY(U,$J,358.3,6643,0)
 ;;=250.00^^37^405^34
 ;;^UTILITY(U,$J,358.3,6643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6643,1,3,0)
 ;;=3^Dm Type II, No Retinopathy
 ;;^UTILITY(U,$J,358.3,6643,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,6643,2)
 ;;=DM Type II, No Retinopathy^33605
 ;;^UTILITY(U,$J,358.3,6644,0)
 ;;=250.01^^37^405^33
 ;;^UTILITY(U,$J,358.3,6644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6644,1,3,0)
 ;;=3^Dm Type I, No Retinopathy
 ;;^UTILITY(U,$J,358.3,6644,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,6644,2)
 ;;=DM Type I, No Retinopathy^33586
 ;;^UTILITY(U,$J,358.3,6645,0)
 ;;=250.50^^37^405^25
 ;;^UTILITY(U,$J,358.3,6645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6645,1,3,0)
 ;;=3^Csme In DM Type II
 ;;^UTILITY(U,$J,358.3,6645,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,6645,2)
 ;;=CSME in DM type II^267839^362.83
 ;;^UTILITY(U,$J,358.3,6646,0)
 ;;=250.51^^37^405^27
 ;;^UTILITY(U,$J,358.3,6646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6646,1,3,0)
 ;;=3^DM Type I w/ Ophtharlmic Manifestation
 ;;^UTILITY(U,$J,358.3,6646,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,6646,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,6647,0)
 ;;=362.01^^37^405^32
 ;;^UTILITY(U,$J,358.3,6647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6647,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,6647,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,6647,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,6648,0)
 ;;=362.02^^37^405^72
 ;;^UTILITY(U,$J,358.3,6648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6648,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,6648,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,6648,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,6649,0)
 ;;=362.03^^37^405^64
 ;;^UTILITY(U,$J,358.3,6649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6649,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,6649,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,6649,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,6650,0)
 ;;=362.04^^37^405^61
 ;;^UTILITY(U,$J,358.3,6650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6650,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,6650,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,6650,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,6651,0)
 ;;=362.05^^37^405^62
 ;;^UTILITY(U,$J,358.3,6651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6651,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,6651,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,6651,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,6652,0)
 ;;=362.06^^37^405^98
 ;;^UTILITY(U,$J,358.3,6652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6652,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,6652,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,6652,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,6653,0)
 ;;=379.27^^37^405^103
 ;;^UTILITY(U,$J,358.3,6653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6653,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,6653,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,6653,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,6654,0)
 ;;=115.02^^37^405^44
 ;;^UTILITY(U,$J,358.3,6654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6654,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,6654,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,6654,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,6655,0)
 ;;=190.5^^37^405^58
 ;;^UTILITY(U,$J,358.3,6655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6655,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,6655,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,6655,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,6656,0)
 ;;=198.4^^37^405^59
 ;;^UTILITY(U,$J,358.3,6656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6656,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,6656,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,6656,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,6657,0)
 ;;=200.00^^37^405^81
 ;;^UTILITY(U,$J,358.3,6657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6657,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,6657,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,6657,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,6658,0)
 ;;=228.03^^37^405^38
 ;;^UTILITY(U,$J,358.3,6658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6658,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,6658,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,6658,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,6659,0)
 ;;=228.09^^37^405^39
 ;;^UTILITY(U,$J,358.3,6659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6659,1,3,0)
 ;;=3^Hemangioma,Oth Sites
 ;;^UTILITY(U,$J,358.3,6659,1,4,0)
 ;;=4^228.09
 ;;^UTILITY(U,$J,358.3,6659,2)
 ;;=^55270
 ;;^UTILITY(U,$J,358.3,6660,0)
 ;;=360.00^^37^405^73
 ;;^UTILITY(U,$J,358.3,6660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6660,1,3,0)
 ;;=3^Purulent Endophthalmitis,Unspec
 ;;^UTILITY(U,$J,358.3,6660,1,4,0)
 ;;=4^360.00
 ;;^UTILITY(U,$J,358.3,6660,2)
 ;;=^40605
 ;;^UTILITY(U,$J,358.3,6661,0)
 ;;=360.03^^37^405^21
 ;;^UTILITY(U,$J,358.3,6661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6661,1,3,0)
 ;;=3^Chronic Endophthalmitis
 ;;^UTILITY(U,$J,358.3,6661,1,4,0)
 ;;=4^360.03
 ;;^UTILITY(U,$J,358.3,6661,2)
 ;;=^268547
 ;;^UTILITY(U,$J,358.3,6662,0)
 ;;=361.02^^37^405^76
 ;;^UTILITY(U,$J,358.3,6662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6662,1,3,0)
 ;;=3^Recent RD w/ Multiple Defects
 ;;^UTILITY(U,$J,358.3,6662,1,4,0)
 ;;=4^361.02
 ;;^UTILITY(U,$J,358.3,6662,2)
 ;;=^268587
 ;;^UTILITY(U,$J,358.3,6663,0)
 ;;=361.03^^37^405^75
 ;;^UTILITY(U,$J,358.3,6663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6663,1,3,0)
 ;;=3^Recent RD w/ Giant Tear
 ;;^UTILITY(U,$J,358.3,6663,1,4,0)
 ;;=4^361.03
 ;;^UTILITY(U,$J,358.3,6663,2)
 ;;=^268588
 ;;^UTILITY(U,$J,358.3,6664,0)
 ;;=361.04^^37^405^79
 ;;^UTILITY(U,$J,358.3,6664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6664,1,3,0)
 ;;=3^Ret Det,Partial w/ Dialysis
 ;;^UTILITY(U,$J,358.3,6664,1,4,0)
 ;;=4^361.04
 ;;^UTILITY(U,$J,358.3,6664,2)
 ;;=^268589
 ;;^UTILITY(U,$J,358.3,6665,0)
 ;;=361.12^^37^405^8
 ;;^UTILITY(U,$J,358.3,6665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6665,1,3,0)
 ;;=3^Bullous Retinoschisis
 ;;^UTILITY(U,$J,358.3,6665,1,4,0)
 ;;=4^361.12
 ;;^UTILITY(U,$J,358.3,6665,2)
 ;;=^268596
 ;;^UTILITY(U,$J,358.3,6666,0)
 ;;=361.2^^37^405^102
 ;;^UTILITY(U,$J,358.3,6666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6666,1,3,0)
 ;;=3^Uveal Effusion/SRD
 ;;^UTILITY(U,$J,358.3,6666,1,4,0)
 ;;=4^361.2
 ;;^UTILITY(U,$J,358.3,6666,2)
 ;;=^268601
 ;;^UTILITY(U,$J,358.3,6667,0)
 ;;=361.9^^37^405^83
 ;;^UTILITY(U,$J,358.3,6667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6667,1,3,0)
 ;;=3^Retinal Detachment NOS
 ;;^UTILITY(U,$J,358.3,6667,1,4,0)
 ;;=4^361.9
 ;;^UTILITY(U,$J,358.3,6667,2)
 ;;=^105529
 ;;^UTILITY(U,$J,358.3,6668,0)
 ;;=362.10^^37^405^95
 ;;^UTILITY(U,$J,358.3,6668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6668,1,3,0)
 ;;=3^Rubella Retinopathy
 ;;^UTILITY(U,$J,358.3,6668,1,4,0)
 ;;=4^362.10
 ;;^UTILITY(U,$J,358.3,6668,2)
 ;;=^12267
 ;;^UTILITY(U,$J,358.3,6669,0)
 ;;=362.12^^37^405^22
 ;;^UTILITY(U,$J,358.3,6669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6669,1,3,0)
 ;;=3^Coats' Disease
 ;;^UTILITY(U,$J,358.3,6669,1,4,0)
 ;;=4^362.12
 ;;^UTILITY(U,$J,358.3,6669,2)
 ;;=^268612
 ;;^UTILITY(U,$J,358.3,6670,0)
 ;;=362.13^^37^405^88
 ;;^UTILITY(U,$J,358.3,6670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6670,1,3,0)
 ;;=3^Retinal Vascular Changes
 ;;^UTILITY(U,$J,358.3,6670,1,4,0)
 ;;=4^362.13
 ;;^UTILITY(U,$J,358.3,6670,2)
 ;;=^268614
 ;;^UTILITY(U,$J,358.3,6671,0)
 ;;=362.14^^37^405^82
 ;;^UTILITY(U,$J,358.3,6671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6671,1,3,0)
 ;;=3^Retina Microaneurysm NOS
 ;;^UTILITY(U,$J,358.3,6671,1,4,0)
 ;;=4^362.14
 ;;^UTILITY(U,$J,358.3,6671,2)
 ;;=^268615
 ;;^UTILITY(U,$J,358.3,6672,0)
 ;;=362.17^^37^405^52
 ;;^UTILITY(U,$J,358.3,6672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6672,1,3,0)
 ;;=3^Macroaneurysm
 ;;^UTILITY(U,$J,358.3,6672,1,4,0)
 ;;=4^362.17
 ;;^UTILITY(U,$J,358.3,6672,2)
 ;;=^268617
 ;;^UTILITY(U,$J,358.3,6673,0)
 ;;=362.21^^37^405^71
 ;;^UTILITY(U,$J,358.3,6673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6673,1,3,0)
 ;;=3^Prematurity-ROP
 ;;^UTILITY(U,$J,358.3,6673,1,4,0)
 ;;=4^362.21
 ;;^UTILITY(U,$J,358.3,6673,2)
 ;;=^105733
 ;;^UTILITY(U,$J,358.3,6674,0)
 ;;=362.29^^37^405^63
 ;;^UTILITY(U,$J,358.3,6674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6674,1,3,0)
 ;;=3^Nondiabetic PR
 ;;^UTILITY(U,$J,358.3,6674,1,4,0)
 ;;=4^362.29
 ;;^UTILITY(U,$J,358.3,6674,2)
 ;;=^268619
 ;;^UTILITY(U,$J,358.3,6675,0)
 ;;=362.30^^37^405^40
 ;;^UTILITY(U,$J,358.3,6675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6675,1,3,0)
 ;;=3^Hemiretinal Vein Occlusion
 ;;^UTILITY(U,$J,358.3,6675,1,4,0)
 ;;=4^362.30
 ;;^UTILITY(U,$J,358.3,6675,2)
 ;;=^105640
 ;;^UTILITY(U,$J,358.3,6676,0)
 ;;=362.37^^37^405^9
